
⟳ Martin Voss retweeted
I love early phase studies evaluating a clear hypothesis, with rich correlatives. Great example from @KotechaMD @MSK_DeptOfMed looking at talazoparib and axitinib in pts with kidney cancer #ASCO24 @MVossMD
✓GU Oncologist, Memorial Sloan Kettering Cancer Center, New York @MSKCC

I love early phase studies evaluating a clear hypothesis, with rich correlatives. Great example from @KotechaMD @MSK_DeptOfMed looking at talazoparib and axitinib in pts with kidney cancer #ASCO24 @MVossMD

Interesting RWD showing superior clinical outcomes in 1L with doublet regimens containing targeted therapy compared to monotherapies in pts with #chromophobe RCC! @MVossMD @ASCO @OncoAlert #ASCO24